Who is sponsoring NCT03784612?

NCT03784612 is sponsored by Karolinska Institutet.

What drugs are being tested in NCT03784612?

Interventions in NCT03784612: App-technology for healthy eating habits.

What condition does NCT03784612 study?

NCT03784612 studies Type 2 Diabetes Mellitus, Dietary Habits.

Is NCT03784612 still recruiting?

NCT03784612 is currently completed. Last updated 22 November 2024.

Last reviewed 2024-11-22 · How we verify

NCT03784612: HAPPY

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Healthy Eating with APP TechnologY Study

Completed NA Last updated 22 November 2024

What this trial tests

NA trial testing App-technology for healthy eating habits in Type 2 Diabetes Mellitus in 133 participants. Completed in 31 August 2023.

Timeline

15 January 2019

Primary endpoint
31 August 2023

31 August 2023

Quick facts

Lead sponsor	Karolinska Institutet
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	133
Start date	15 January 2019
Primary completion	31 August 2023
Estimated completion	31 August 2023
Sites	1 location across Sweden

Drugs / interventions tested

App-technology for healthy eating habits

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Dietary Habits — all drugs for Dietary Habits →

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Type 2 Diabetes Mellitus or Dietary Habits. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of using new app-based technology to improve dietary habits, compared to usual care in patients with type 2 diabetes. The hypothesis is that the intervention, i.e. using the new technology an an app-based course for healthy eating habits, will have a greater positive effect on dietary habits and biological markers, including HbA1c and serum lipids, than usual care.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Digital Support for Healthier Eating Habits Among Patients With Type 2 Diabetes: Protocol for a Randomized Clinical Trial Within Primary Care (HAPPY Trial).
Trolle Lagerros Y, Dahlgren A, Sjöblom L, Bonn SE. · · 2020 · cited 7× · PMID 33196448 · DOI 10.2196/24422
The effect of an app-based dietary education on dietary intake and cardiometabolic risk markers in people with type 2 diabetes: results from a randomized controlled trial.
Sjöblom L, Hantikainen E, Dahlgren A, Trolle Lagerros Y, et al · · 2025 · cited 6× · PMID 39754157 · DOI 10.1186/s12937-024-01069-2
The effect of an app-based dietary intervention on diet-related greenhouse gas emissions - results from a randomized controlled trial.
Pitt S, Sjöblom L, Bälter K, Trolle Lagerros Y, et al · · 2023 · cited 2× · PMID 37821876 · DOI 10.1186/s12966-023-01523-0
The Effect of a Mobile Health Dietary Education Intervention on Ultra-processed Food Consumption in Patients with Type 2 Diabetes: A Randomized Controlled Trial.
Cecchini V, Sjöblom L, Lagerros YT, Bonn SE. · · 2025 · PMID 40510749 · DOI 10.1016/j.cdnut.2025.107454
Engagement With a Smartphone-Delivered Dietary Education Intervention and Its Relation to Dietary Intake and Cardiometabolic Risk Markers in People With Type 2 Diabetes: Secondary Analysis of a Randomized Controlled Trial.
Sjoblom L, Stenbeck F, Trolle Lagerros Y, Hantikainen E, et al · · 2025 · PMID 40446320 · DOI 10.2196/71408

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Karolinska Institutet trials

Trials by the same sponsor.

NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03784612 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
Last refreshed: 22 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03784612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing